Hanjoon Alex Kim - 20 May 2024 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Chief Operating Officer
Signature
/s/ Hanjoon Alex Kim by Agnieszka Gallagher, Attoney-in-Fact
Issuer symbol
LAB
Transactions as of
20 May 2024
Transactions value $
$0
Form type
4
Filing time
21 May 2024, 17:34:52 UTC
Previous filing
05 Apr 2024
Next filing
24 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Award $0 +333K +157.93% $0.00 544K 20 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Stock Option (Right to Buy) Award $0 +750K $0.00 750K 20 May 2024 Common Stock 750K $2.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that vest as to 1/16th of the RSUs on August 20, 2024, with the remaining RSUs vesting in equally quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2 The Option becomes exercisable as to 1/16th of the underlying shares on August 20, 2024, with the remaining shares vesting in equal quarterly installments over four years thereafter, subject to the Reporting Person's continued service through the applicable vesting date.